Alfacell’s Onconase shows promise as radiation sensitizer for lung cancer treatment
Co announces that Intae Lee with the University of Pennsylvania has reported that Alfacell’s Onconase could be a promising radiation sensitizer for lung cancer treatment. Lee presented the pre- clinical in vivo data at the American Society for Therapeutic Radiology and Oncology 49th Annual Meeting. Lee provided pre-clinical evidence that Onconase significantly increased the radiation-induced tumor growth delay of lung tumors in vivo without increases in skin reaction compared to radiation alone.
This entry was posted on Tuesday, October 30th, 2007 at 5:45 pm and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.